Corbus Pharmaceuticals
CRBP
#8688
Rank
HK$1.41 B
Marketcap
HK$79.71
Share price
1.90%
Change (1 day)
103.59%
Change (1 year)

Market capitalization of Corbus Pharmaceuticals (CRBP)

Market cap: HK$1.41 Billion

As of April 2026 Corbus Pharmaceuticals has a market cap of HK$1.41 Billion. This makes Corbus Pharmaceuticals the world's 8688th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corbus Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$1.41 B24.27%
2025HK$1.13 B-5.63%
2024HK$1.20 B477.73%
2023HK$0.20 B92.93%
2022HK$0.10 B-82.01%
2021HK$0.60 B-26.17%
2020HK$0.81 B-70.39%
2019HK$2.75 B5.04%
2018HK$2.61 B-15.07%
2017HK$3.08 B5.87%
2016HK$2.91 B505.47%
2015HK$0.48 B-20.05%
2014HK$0.60 B

End of Day market cap according to different sources

On Apr 1st, 2026 the market cap of Corbus Pharmaceuticals was reported to be:

HK$1.38 Billion
by Nasdaq info icon info icon
HK$1.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Viking Therapeutics
VKTX
HK$31.51 B 2,129.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
HK$3.24 B 129.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Epizyme
EPZM
HK$1.93 B 37.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
HK$10.01 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA